STRO

Sutro Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and manufacturing of innovative antibody-drug conjugates (ADCs) using its proprietary cell-free protein synthesis platform. Based in South San Francisco, California, Sutro is committed to advancing a robust pipeline of targeted therapies for cancer and other serious diseases. With its unique capabilities in protein engineering and biologics manufacturing, the company aims to address unmet medical needs through precision medicine and is well-positioned for growth and partnership opportunities in the evolving biopharmaceutical landscape.